Bioworld Financial Watch articles from June 2008

Bioworld Financial Watch archives from June 2008

States attracting biotech by extending NOL carry forward.(net operating loss)
June 2, 2008... With a federal tax benefit that allows young companies to carry forward 20 years of net losses, more states are following in papa's footsteps in order to incentivize innovation and attract the high-wage biotech industry within its borders. ...

Money raised by biotech in 2008 vs. 2007.(Table)(Brief article)
June 2, 2008... Jan. 1 - May 29, 2008: Jan. 1 - May 31, 2007: $5,158.39M $10,106.71M Public Offerings 1,284 3,038 Public/Other * 2,241 ...

10 biggest U.S. gainers for the week.(Statistical table)(Brief article)
June 2, 2008... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Kosan Biosciences 243.04 Alexion Pharma 4.57 EpiCept 64.71 Kosan Biosciences 3.84 DOV Pharma 25.00 United...

10 biggest U.S. losers for the week.(Statistical table)(Brief article)
June 2, 2008... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Favrille -94.25 Favrille -1.64 Oxis Intl. -44.44 Sangamo Biosciences -1.18 Introgen Thera -25.72 Genomic Health, Inc. -0.99...

Collaborations between biotechnology companies and government/nonprofit institutions: Feb. 29 - May 29, 2008.(Table)
June 2, 2008... Collaborations Between Biotechnology Companies And Government/Nonprofit Institutions: Feb. 29 - May 29, 2008 Company * University/ Type Of (Country; Symbol) Nonprofit @ Agreement 3M Drug ...

BioWorld stock report for public biotechnology companies.(Market share report)(Table)
June 2, 2008... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 5/23 5/30 WK YTD (000) Aastrom Biosci ASTM 0.39 0.39 ...

ASCO shows incremental moves, not game-changers.(American Society of Clinical Oncology)
June 9, 2008... While there was an abundance of data presented last week at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, most of it was incremental in terms of the impact on clinical practice, analysts said. Data from...

Money raised by biotech in 2008 vs. 2007.(Table)(Brief article)
June 9, 2008... Money Raised By Biotech In 2008 Vs. 2007 Jan. 1 - June 5, 2008: Jan. 1 - June 7, 2007: $5,385.10M $15,534.26M Public Offerings 1,293 3,349...

10 biggest U.S. gainers for the week.(Statistical table)(Brief article)
June 9, 2008... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Tercica 106.57 Acorda Therapeutics 9.17 Sequenom 54.36 OSI Pharma 4.65 Inovio Biomedical 43.90...

10 biggest U.S. losers for the week.(Statistical table)(Brief article)
June 9, 2008... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Indevus Pharma -69.27 Regeneron Pharma -5.08 Alliance Pharma -33.33 Gen-Probe -4.41 Favrille -30.00 Indevus Pharma ...

Public financing of biotechnology: May 2008.(Table)
June 9, 2008... Public Financing Of Biotechnology: May 2008 I. COMMENCED TRADING IN MAY Company Date Date Shares/Units (M) Price Shares Out # (Symbol) Filed Comm (M) @ INITIAL OFFERINGS ...

Other financings of public biotechnology companies: May 2008.(Table)
June 9, 2008... Other Financings Of Public Biotechnology Companies: May 2008 TOTAL: $422.56M Company # Type Of Financing Number Of Amount Raised (M) (Symbol) Shares, ...

Venture capital and other investments in private biotechnology companies: May 2008.(Table)
June 9, 2008... FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $239.9M Company Location Date Amt. (M) Details ACT Biotech San 5/7 $12 ACT raised $12M in a Inc. Francisco ...

Milestone payments from corporate partners: May 2008.(Table)
June 9, 2008... Milestone Payments From Corporate Partners: May 2008 TOTAL: $38.25M Year to Date: $186.62M Company Partner Amt. Details (Date) (Symbol) #* (Country) (M) Antisoma plc Novartis AG $25...

Money raised by biotech in 2008: January - May.(Statistical table)(Brief article)
June 9, 2008... Money Raised By Biotech In 2008: January - May Type of financing January February March April May Total ($M) Public offerings 413.6 689.9 89.9 0.0 99.9 1,293.33 Public/other 352.0 578.3 277.3...

BioWorld stock indicator 2008.(Brief article)
June 9, 2008... These graphs compare the performance of the biotech stocks for all of 2008 using two different measures. The BioWorld Stock Indicator measures the average percent change year to date in the 243 U.S. biotech and biotech-related stocks that...

BioWorld stock report for public biotechnology companies.(Market share report)(Table)
June 9, 2008... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 5/30 6/06 WK YTD (000) Aastrom Biosci ASTM 0.39 0.42 7.69...

Companion diagnostics gaining ground, but slowly.
June 16, 2008... The 13-year Human Genome Project, which got under way in late 1990, stirred visions of finding cures to devastating diseases and creating therapy personalized for individual patients based on genetic and disease biomarkers. But, since its...

Money raised by biotech in 2008 vs. 2007.(Statistical table)(Brief article)
June 16, 2008... Money Raised By Biotech In 2008 Vs. 2007 Jan. 1 - June 12, 2008: Jan. 1 - June 14, 2007: $5,433.62M $15,933.40M Public Offerings 1,305 3,531...

10 biggest U.S. gainers for the week.(Statistical table)(Brief article)
June 16, 2008... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Sequenom 25.86 Sequenom 3.07 Oxis Intl. 25.00 Integra LifeSci 2.09 SGX Phanna 21.74 Enzo Biochem 1.7...

10 biggest U.S. losers for the week.(Statistical table)(Brief article)(Company rankings)
June 16, 2008... (By Percent) (By Dollars) Maxygen -38.56 Invitrogen -6.41 DOV Pharma -33.33 BioMarin Pharma -4.19 Bioheart Inc -26.05 Amylin Pharma -2.9 CytRx ...

Phase I clinical trials update: May 2008.(Table)
June 16, 2008... Phase I Clinical Trials Update: May 2008 Company * (Country; Product Description Symbol) AUTOIMMUNE ChemoCentryx Inc. * CCX354 An oral small molecule ...

Phase II clinical trials update: May 2008.(Table)
June 16, 2008... Phase II Clinical Trials Update: May 2008 Company * (Country; Product Description Symbol) AUTOIMMUNE Alba Therapeutics Oral larazotide An inhibitor of Corp. * acetate ...

Pivotal/phase III clinical trials update: May 2008.(Table)
June 16, 2008... Pivotal/Phase III Clinical Trials Update: May 2008 Company * (Country; Product Description Symbol) AUTOIMMUNE NicOx SA (France; Naproxcinod COX-inhibiting nitric PARIS: COX) ...

American Society of clinical oncology: May 2008.(Table)
June 16, 2008... American Society Of Clinical Oncology: May 2008 (This section includes news released prior to the ASCO meeting held May 30 through June 3 in Chicago.) Company * (Country; Product Description Symbol) Adventrx...

Non-U.S. clinical trials and regulatory actions: May 2008.(Table)
June 16, 2008... Non-U.S. Clinical Trials And Regulatory Actions: May 2008 Company * Product Description Indication (Country; Symbol) AUTOIMMUNE Basilea Alitretinoin Oral therapy Severe refractory...

FDA submissions, approvals and other actions: May 2008.(nited States. Food and Drug Administration)(Table)
June 16, 2008... FDA Submissions, Approvals And Other Actions: May 2008 Company * (Country; Product Description Symbol) CANCER GlaxoSmithKline plc Rezonic/Zunrisa Casopitant; NK-1 (UK) ...

BioWorld stock report for public biotechnology companies.(Statistical table)
June 16, 2008... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 6/6 6/13 WK YTD (000) Aastrom Biosci ASTM 0.42 0.42 0.00...

Rare pulmonary fibrosis may have blockbuster potential.(Financial report)
June 23, 2008... A handful of companies are working to develop a treatment for a rare lung disorder called pulmonary fibrosis that, by some estimates, could present a $500 million to $1.5 billion market opportunity. "It is probably a commercially...

Money raised by biotech in 2008 vs. 2007.(Statistical table)(Brief article)
June 23, 2008... Jan. 1 - June 19, 2008: Jan. 1 - June 21, 2007: $5,544.50M $16,621.48M Public Offerings 1,305 3,716 Public/Other * 2,330 ...

10 biggest U.S. gainers for the week.(Brief article)
June 23, 2008... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Vanda Pharma 28.83 Illumina 6.06 Jazz 26.67 Myriad Genetics 4.69 Santarus 20.40 IDEXX Laboratories ...

10 biggest U.S. losers for the week.(Brief article)
June 23, 2008... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Oxis Intl. -80.00 Acadia Pharma -4.41 Acadia Phanna -51.94 Gen-Probe -4.12 Neose Technologies -38.71 Kinetic Concepts...

Biotechnology company deals with other biotechnology companies: May 16 - June 19, 2008.
June 23, 2008... Biotechnology Company Deals With Other Biotechnology Companies: May 16 - June 19, 2008 Company * (Country; Company * (Country; Type/Product Area Symbol) Symbol) AMAG Pharmaceuticals 3SBio Inc. (SSRX) ...

Biotechnology company deals with miscellaneous companies: May 16 - June 19, 2008.(Brief article)
June 23, 2008... Biotechnology Company Deals With Miscellaneous Companies: May 16-June 19, 2008 Company * Company Type/Product Area Terms/Details (Date) (Country; Symbol) Lev CuraScript, Multiyear The product...

Manufacturing, marketing and distribution agreements between biotech companies: May 16 - June 19, 2008.
June 23, 2008... Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: May 16 - June 19, 2008 Company * Company * Type/Product Terms/Details (Date) (Country; (Country; Area Symbol) ...

Biotech--biotech collaborations: modified agreements: May 16 - June 19, 2008.
June 23, 2008... Biotech--Biotech Collaborations: Modified Agreements: May 16 - June 19, 2008 Company * Company Type/Product Terms/Details (Date) (Country; (Country; Area Symbol) Symbol) I. MODIFIED AGREEMENTS...

BioWorld stock report for public biotechnology companies.(Market share report)(Statistical table)
June 23, 2008... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 6/13 6/20 WK YTD (000) Aastrom Biosci ASTM 0.42 0.38 -9.52...

Amitiza ok fills IBS need but there's room for more.(irritable bowel syndrome )
June 30, 2008... Women suffering from irritable bowel syndrome (IBS) found something to settle their stomachs in May when the FDA cleared the way for Amitiza, a chloride channel activator that alleviates constipation, but analysts and biotechs alike contend...

Money raised by biotech in 2008 vs. 2007.(Brief article)
June 30, 2008... Money Raised By Biotech In 2008 Vs. 2007 Jan. 1 - June 26, 2008: Jan. 1 -June 28, 2007: $5,695.50M $16,966.23M Public Offerings 1,390 3,716 ...

10 biggest U.S. gainers for the week.(Brief article)
June 30, 2008... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Oxis Intl. 300.00 Alexion Pharma 4.00 Barrier Therapeutics 128.98 Celgene 3.75 Critical Therapeutics 28.57...

10 biggest U.S. losers for the week.(Brief article)
June 30, 2008... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Vanda Pharma -40.63 Cephalon -3.54 EpiCept -35.90 BioMarin Pharma -2.93 Tapestry Pharma -33.33 Vanda Pharma -2.56...

Collaborations between biotech and pharmaceutical companies: May 23 - June 26, 2008 #.
June 30, 2008... Collaborations Between Biotech And Pharmaceutical Companies: May 23 - June 26, 2008 # Biotech Co. * Pharma Co. Type/Product Area (Country; (Country) Symbol) Access Jiangsu Licensing...

Manufacturing, marketing and distribution agreements between biotech and pharmaceutical companies: May 23 - June 26, 2008.
June 30, 2008... Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: May 23 - June 26, 2008 # Biotech Co. * Pharma Co. Type/Product Area Terms/Details (Country; (Country) ...

Biotech--big pharma collaborations: modified and terminated agreements, May 23 - June 26, 2008.
June 30, 2008... Biotech--Big Pharma Collaborations: Modified And Terminated Agreements, May 23 - June 26, 2008 # I. MODIFIED AGREEMENTS Biotech Co. * Pharma Co. Change from Terms/Details (Country; (Country) ...

Clinical Trial Agreements: getting it right.
June 30, 2008... One of the most important and challenging aspects of the clinical trial business is outsourcing trials. Getting the wrong contract in place or having an erroneous provision in the agreement can subject you to injury lawsuits. You cannot protect...

BioWorld stock report for public biotechnology companies.(Market share report)(Statistical table)
June 30, 2008... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 6/20 6/27 WK YTD (000) Aastrom Biosci ASTM 0.38 0.35...